Literature DB >> 27107764

Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia.

Wolfram An der Heiden1, Anne Leber1, Heinz Häfner2.   

Abstract

Depressive symptoms abound in schizophrenia and even in subclinical states of the disorder. We studied the frequency of these symptoms and their relationship to negative symptoms from the first psychotic episode on over a long-term course of 134 months on data for 107 patients in our ABC Schizophrenia Study. Prevalence rates of 90 % for presenting at least one negative symptom and of 60 % for presenting at least one depressive symptom in the first psychotic episode illustrate the frequency of these syndromes. After the remission of psychosis the rates fell to 50 % (negative symptoms) and 40 % (depressive symptoms) over a period of 5 years, remaining stable thereafter. After we broke the negative syndrome down into (SANS) subsyndromes, a positive association emerged between anhedonia and depressive symptoms and remained stable over the entire period studied. In contrast, the association between abulia and depression grew increasingly pronounced over the illness course. However, a more detailed look revealed this to be the case in female patients only, whereas male patients showed no such association of these symptom dimensions. We have no explanation at hand for this sex difference yet.

Entities:  

Keywords:  Depressive symptoms; Long-term course; Negative symptoms; Schizophrenia; Sex differences

Mesh:

Year:  2016        PMID: 27107764     DOI: 10.1007/s00406-016-0697-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  53 in total

1.  Prodromal states in schizophrenia.

Authors:  W Gaebel; M Jänner; N Frommann; A Pietzcker; W Köpcke; M Linden; P Müller; F Müller-Spahn; J Tegeler
Journal:  Compr Psychiatry       Date:  2000 Mar-Apr       Impact factor: 3.735

2.  The nature and prevalence of depression in chronic schizophrenic in-patients.

Authors:  T R Barnes; D A Curson; P F Liddle; M Patel
Journal:  Br J Psychiatry       Date:  1989-04       Impact factor: 9.319

3.  Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.

Authors:  R A Emsley; P P Oosthuizen; A F Joubert; M C Roberts; D J Stein
Journal:  J Clin Psychiatry       Date:  1999-11       Impact factor: 4.384

4.  Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders.

Authors:  V Peralta; M J Cuesta
Journal:  Schizophr Res       Date:  1999-07-27       Impact factor: 4.939

5.  Specificity of the Calgary Depression Scale for schizophrenics.

Authors:  D Addington; J Addington; E Maticka-Tyndale
Journal:  Schizophr Res       Date:  1994-02       Impact factor: 4.939

6.  Alcoholism and other psychiatric disorders.

Authors:  M A Schuckit
Journal:  Hosp Community Psychiatry       Date:  1983-11

Review 7.  Behavioral toxicity of antipsychotic drugs.

Authors:  T Van Putten; S R Marder
Journal:  J Clin Psychiatry       Date:  1987-09       Impact factor: 4.384

8.  Depression and the experience of psychological deficits in schizophrenia.

Authors:  P F Liddle; T R Barnes; D A Curson; M Patel
Journal:  Acta Psychiatr Scand       Date:  1993-10       Impact factor: 6.392

9.  Evidence for separate diseases?: Stages of one disease or different combinations of symptom dimensions?

Authors:  Heinz Häfner; Wolfram an der Heiden; Kurt Maurer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

10.  Depression in people with first-episode schizophrenia.

Authors:  D Addington; J Addington; S Patten
Journal:  Br J Psychiatry Suppl       Date:  1998
View more
  13 in total

1.  Impaired recovery in affective disorders and schizophrenia: sharing a common pathophysiology?

Authors:  Peter Falkai; Andrea Schmitt; Nikolaos Koutsouleris
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-12       Impact factor: 5.270

2.  Negative symptoms, anxiety, and depression as mechanisms of change of a 12-month trial of assertive community treatment as part of integrated care in patients with first- and multi-episode schizophrenia spectrum disorders (ACCESS I trial).

Authors:  Stefanie J Schmidt; Matthias Lange; Daniel Schöttle; Anne Karow; Benno G Schimmelmann; Martin Lambert
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-05-24       Impact factor: 5.270

3.  Psychosis and Psychotic-Like Symptoms Affect Cognitive Abilities but Not Motivation in a Foraging Task.

Authors:  Wenche Ten Velden Hegelstad; Isabel Kreis; Håkon Tjelmeland; Gerit Pfuhl
Journal:  Front Psychol       Date:  2020-07-31

4.  Correspondence between negative symptoms and potential sources of secondary negative symptoms over time.

Authors:  Aida Farreny; Mark Savill; Stefan Priebe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-02       Impact factor: 5.270

5.  Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study.

Authors:  Siv Hege Lyngstad; Erlend Strand Gardsjord; Magnus Johan Engen; Beathe Haatveit; Henrik Myhre Ihler; Kirsten Wedervang-Resell; Carmen Simonsen; Ingrid Melle; Ann Færden
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-03-04       Impact factor: 5.270

6.  Gender Differences of Schizophrenia Patients With and Without Depressive Symptoms in Clinical Characteristics.

Authors:  Ruimei Liu; Xinyu Fang; Lingfang Yu; Dandan Wang; Zenan Wu; Chaoyue Guo; Xinyue Teng; Juanjuan Ren; Chen Zhang
Journal:  Front Psychiatry       Date:  2022-01-13       Impact factor: 4.157

7.  Prevalence, Influencing Factors, and Cognitive Characteristics of Depressive Symptoms in Elderly Patients with Schizophrenia.

Authors:  Yaopian Chen; Wei Li
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-14       Impact factor: 2.570

Review 8.  Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits.

Authors:  David R Goldsmith; Mark Hyman Rapaport
Journal:  Front Psychiatry       Date:  2020-02-20       Impact factor: 4.157

Review 9.  Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment.

Authors:  Christoph U Correll; Nina R Schooler
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-21       Impact factor: 2.570

10.  Self-reported neurocognitive symptoms during COVID-19 lockdown and its associated factors in a sample of psychiatric patients. Results from the BRIS-MHC study.

Authors:  Laura Montejo; Brisa Solé; Norma Verdolini; Anabel Martínez-Arán; Caterina Del Mar Bonnín; Joaquim Radua; Inés Martín-Villalba; Evelin Williams; Clemente García-Rizo; Gisela Mezquida; Miguel Bernardo; Eduard Vieta; Carla Torrent; Silvia Amoretti
Journal:  Eur Neuropsychopharmacol       Date:  2021-07-20       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.